Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation
NCT02985775
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
CMV Infection
Interventions
BIOLOGICAL:
Donor-derived CMVpp65-specific T cells
Sponsor
Peking University People's Hospital